FIRST-QUARTER 2020 RESULTS PRESENTATIONMay 5, 2020

|2

DISCLOSURES

Forward-Looking Statements

This presentation contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements by our CEO and CFO

and statements regarding our business strategies and ability to execute on our plans, market potential, future financial performance, customer demand, the potential of our categories, brands and innovations,

the impact of our footprint rationalization and modernization program, our pipeline of productivity projects, the estimated impact of tax reform on our results, litigation outcomes, our outlook for the second

quarter, and our expectations, beliefs, plans, objectives, prospects, assumptions, or other future events. Forward-looking statements are generally identified by our use of forward-looking terminology such as

“anticipate”, “believe”, “continue”, “could”, “estimate”, “expect”, “intend”, “may”, “might”, “plan”, “potential”, “predict”, “seek”, or “should”, or the negative thereof or other variations thereon or comparable

terminology. Where, in any forward-looking statement, we express an expectation or belief as to future results or events, such expectation or belief is based on the current plans, expectations, assumptions,

estimates, and projections of our management. Although we believe that these statements are based on reasonable expectations, assumptions, estimates and projections, they are only predictions and involve

known and unknown risks, many of which are beyond our control that could cause actual outcomes and results to be materially different from those indicated in such statements.

Risks and uncertainties that could cause actual results to differ materially from such statements include risks associated with the impact of the COVID-19 pandemic on the company and our employees,

customers and suppliers, risk that our current assumption of the decline in volume in the second quarter will be greater than our current estimates and other factors, including the factors discussed in our Annual

Reports on Form 10-K and our other filings filed with the Securities and Exchange Commission.

The forward-looking statements included in this presentation are made as of the date hereof, and except as required by law, we undertake no obligation to update, amend or clarify any forward-looking

statements to reflect events, new information or circumstances occurring after the date of this presentation.

Non-GAAP Financial Measures

This presentation presents certain “non-GAAP” financial measures. The components of these non-GAAP measures are computed by using amounts that are determined in accordance with accounting principles

generally accepted in the United States of America (“GAAP”). A reconciliation of non-GAAP financial measures used in this presentation to their nearest comparable GAAP financial measures is included at the

end of this presentation. The company provides certain guidance solely on a non-GAAP basis because the company cannot predict certain elements that are included in certain reported GAAP results, including

the variables and individual adjustments necessary for a reconciliation to GAAP. While management is not able to specifically quantify the reconciliation items for forward-looking non-GAAP measures without

unreasonable effort, the company expects these items to be similar to the types of charges and costs excluded from Adjusted EBITDA in prior periods. Management bases the estimated ranges of non-GAAP

measures for future periods on its reasonable estimates of such factors as assumed effective tax rate, assumed interest expense, stock-based compensation expense, litigation expense, and other assumptions

about capital requirements for future periods. The variability of these items may have a significant impact on our future GAAP financial results.

We use Adjusted EBITDA, Adjusted EBITDA margin, Adjusted net income, and Adjusted EPS because we believe they assist investors and analysts in comparing our operating performance across reporting

periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. Management believes Adjusted EBITDA and Adjusted EBITDA margin are helpful in

highlighting trends because they exclude the results of decisions that are outside the control of management, while other measures can differ significantly depending on long-term strategic decisions regarding

capital structure, the tax jurisdictions in which we operate, and capital investments. We use Adjusted EBITDA and Adjusted EBITDA margin to measure our financial performance and also to report our results to

our board of directors. Further, our executive incentive compensation is based in part on Adjusted EBITDA. In addition, we use Adjusted EBITDA for purposes of calculating compliance with our debt covenants

in certain of our debt facilities. Adjusted EBITDA should not be considered as an alternative to net income as a measure of financial performance or to cash flows from operations as a liquidity measure.

We define Adjusted EBITDA as net income (loss), adjusted for the following items: loss from discontinued operations, net of tax; equity of non-consolidated entities; income tax (benefit) expense; depreciation

and amortization; interest expense, net; impairment and restructuring charges; gain on previously held shares of equity investment; (gain) loss on sale of property and equipment; share-based compensation

expense; non-cash foreign exchange transaction/translation (income) loss; other non-cash items; and costs related to debt restructuring and debt refinancing. Adjusted EBITDA margin is defined as Adjusted

EBITDA divided by net revenues.

We present free cash flow because we believe it assists investors and analysts in determining the quality of our earnings. We also use free cash flow to measure our financial performance and to report to our

board of directors. In addition, our executive incentive compensation is based in part on free cash flow. We define free cash flow as cash flow from operations less capital expenditures (including purchases of

intangible assets). Free cash flow should not be considered as an alternative to cash flows from operations as a liquidity measure.

Adjusted net income represents net income adjusted for certain items as presented in our reconciliation of non-GAAP, including the after-tax impact of i) non-cash foreign currency (gains) losses, ii) impairment

and restructuring charges, iii) one-time, non-cash gains, and iv) other non-recurring expenses associated with certain matters such as mergers and acquisitions, and litigation. Adjusted EPS represents net

income per diluted share adjusted to exclude the estimated per share impact of the same specifically identified items used to calculate adjusted net income as described above. Where applicable such items are

tax-effected at our estimated annual effective tax rate.

Other companies may compute these measures differently. Non-GAAP metrics should not be considered as alternatives to any other measures derived in accordance with GAAP.

Due to rounding, numbers presented throughout this presentation may not sum precisely to the totals provided and percentages may not precisely reflect the absolute figures.

|

INTRODUCTION

Gary Michel, President and CEO

|4

▪ Delivered Q1 Adjusted EBITDA margin of 7.6%, ahead of previous outlook

– Third consecutive quarter of core margin expansion in Europe

– Sixth consecutive quarter of price vs. cost inflation

▪ Q1 revenue declined 3% vs. prior year

– Core revenue growth in North America offset by market weakness in Australasia and Europe

▪ Implemented comprehensive COVID-19 plan focused on safety and business continuity

– COVID-19 financial impact on Q1 results was limited

– Demand and order activity steady through Q1; temporary plant closures in few locations

▪ Footprint rationalization and modernization projects remain in progress

▪ Cash flow performance in line with normal seasonality

▪ Strong liquidity position and financial flexibility due to no near-term debt maturities and no standing

maintenance financial covenants

▪ 2020 full year guidance withdrawn

Q1 PERFORMANCE IN-LINE WITH EXPECTATIONS, MINIMAL IMPACT FROM COVID-19 TO-DATE

Q1 KEY TAKEAWAYS

|5

COVID-19 RESPONSE

FOCUS ON SAFETY, BUSINESS CONTINUITY, EXPENSE REDUCTION AND LIQUIDITY

Safety

• Our priority is the heath and safety of our

associates, partners and customers

• Following guidance of health organizations and

governments

• Manufacturing sites implemented social

distancing, enhanced cleaning, and additional

personal protective equipment

Business Continuity

• Supporting all our customers’ needs is our priority

• Building safety stock inventory where appropriate

• Proactively qualifying alternate sources of supply

and products globally

Cost Reduction

• Implemented comprehensive cost reduction

measures in all regions

• Salary reductions, furloughs, mandatory leave,

elimination of discretionary spend

• Opportunistic actions with supplier base in a

deflationary commodity cost environment

Liquidity and Cash Preservation

• Delaying non-essential capital investments and

deferring tax payments where possible

• Completed $250 million senior secured notes

offering to enhance liquidity and fully repay

precautionary revolver draw down from March

2020

|6

SEGMENT UPDATES

COVID-19 IMPACT EXPECTED TO ACCELERATE AS QUARTER PROGRESSES

North America

Current Status

• Residential new construction

continues in most markets, builder

orders and starts slowing

• R&R retail customers are open

• Sales trend in stock SKUs vs

specials SKUs; online activity up

• Majority of JELD-WEN plants

remain open, absenteeism impact

in certain locations

Europe

Current Status

• COVID-19 pushes flat to low growth

markets into a decline for the region

• Residential markets vary by country

• Non-Residential projects continue;

temporary COVID-19 disruption

• Plant closures in UK & France from

mid-March, those two locations are

~20% of segment revenue

Australasia

Current Status

• Construction markets remain open,

demand down from continuation of

housing contraction

• Direct to builder starting to see

orders beginning to slow

• Showroom traffic down; by

appointment only

• Plants in Malaysia closed due to

government mandate

Q2 Outlook

• Volumes down mid- to high teens

percent vs. prior year

Q2 Outlook

• Volumes down low to mid- teens

percent vs. prior year

Q2 Outlook

• Volumes down high teens percent

vs. prior year

|

FINANCIAL REVIEW

John Linker, Executive Vice President and CFO

|8

REVENUE GROWTH IN NORTH AMERICA NOT SUFFICIENT TO OFFSET HEADWINDS IN EUROPE AND AUSTRALASIA

Q1 2020 FINANCIAL SUMMARYUSD in millions

$89.3$74.5

1Q19 1Q20

Core

(17%)

(16.5%)

$1,010.3$979.2

1Q19 1Q20

Core

(3%)

(3.1%)

8.8%7.6%

1Q19 1Q20

Core

(120 bps)

(120 bps)

Core exc l udes im pac t o f FX and acqu i s i t i ons com p le ted i n t he l as t 12 m on ths .

Adj. EBITDA Adj. EBITDA MarginNET REVENUES

|9

Q1 2020

Pricing 2% 3% 1% (2%)

Volume/Mix (5%) (2%) (4%) (16%)

Core Growth (3%) 1% (3%) (18%)

Acquisitions 2% 3% 0% 0%

FX (2%) 0% (3%) (6%)

Total (3.1%) 3.8% (6.2%) (23.6%)

SIXTH CONSECUTIVE QUARTER OF POSITIVE PRICE/COST REALIZATION

JELD-WEN North America Europe Australasia

Q1 2020 NET REVENUES WALK

Core exc l udes im pac t o f FX and acqu i s i t i ons com p le ted i n t he l as t 12 m on ths .

|10

3.8%

(6.2%)

(23.6%)

CORE REVENUE GROWTH IN NORTH AMERICA

AND CORE MARGIN EXPANSION IN EUROPE

Core exc l udes im pac t o f FX and acqu i s i t i ons com p le ted i n t he l as t 12 m on ths .

Q1 2020 SEGMENT PERFORMANCE

Adj. EBITDA vs. PYAdj. EBITDA Margin bps

vs. PYNET REVENUES vs. PY

As

Re

po

rte

dC

ore

(e

x. F

X &

MA

)

0.5%

(3.0%)

(17.5%)

(7.2%)

(15.6%)

(46.7%)

(100) (90)

(340)

(13.6%)

(1.0%)

(43.4%)

(130)

20

(350)

North America Europe Australasia North America Europe Australasia North America Europe Australasia

|

BALANCE SHEET AND LIQUIDITY OVERVIEW

|12

CASH PERFORMANCE CONSISTENT WITH SEASONAL WORKING CAPITAL CYCLE

Balance Sheet March 28, 2020 December 31, 2019

Total Debt $1,611.9 $1,517.4

Cash $214.3 $226.0

Total Net Debt $1,397.6 $1,291.4

Net Debt / Adjusted EBITDA 3.5x 3.1x

Cash Flow YTD 2020 YTD 2019

Cash Flow From Operations ($76.5) ($28.0)

Capital Expenditures (1) ($30.2) ($31.9)

Free Cash Flow ($106.7) ($59.9)

BALANCE SHEET AND CASH FLOWUSD in mill ions

( 1 ) I n c l u d e s p u r c h a s e s o f p r o p e r t y , e q u i p me n t , a n d i n t a n g i b l e a s s e t s .

|13

STRONG LIQUIDITY POSITION

GLOBAL LIQUIDITY PROFILEUSD in mill ions

L i q u i d i t y i n c l u d e s c a s h a n d a v a i l a b i l i t y f r o m u n d r a wn r e v o l v i n g c r e d i t f a c i l i t i e s .

( 1 ) Q 1 2 0 2 0 l i q u i d i t y p r o f o r ma t o r e f l e c t n e t p r o c e e d s o f $ 2 5 0 mi l l i o n s e n i o r s e c u r e d n o t e s o f f e r i n g c o mp l e t e d o n M a y 4 , 2 0 2 0 a n d

A U $ 3 0 M i n c r e a s e t o A u s t r a l i a n c r e d i t f a c i l i t i e s c o mp l e t e d o n M a y 1 , 2 0 2 0 .

$334 $330 $355

$380

$183

$282

$450

$554

$431

$696

$

$100

$200

$300

$400

$500

$600

$700

$800

Q1 2018 Q2 2018 Q3 2018 Q4 2018 Q1 2019 Q2 2019 Q3 2019 Q4 2019 Q1 2020 Q1 pro forma

Revolver Availability Cash

(1)

|14

COVENANT-LITE STRUCTURE WITH NO NEAR-TERM SIGNIFICANT MATURITIES

LONG-TERM DEBT MATURITY TIMELINEUSD in mill ions

$30

$556

$400 $250

$400 2027

2026

2025

2024

2023

2022

2021

2020

Australian Credit Facilities (AUD 35 million Interchangeable

Facility and AUD 30 million Supplemental Liquidity Facility)

Asset Based Revolver (1) ($400 million): Springing maintenance financial covenant

that applies only when facility is almost fully utilized

Australian Term Loan (AUD 50 million)

Term Loan B: No maintenance financial covenants

4.625% Senior Notes: No maintenance financial covenants

6.250% Senior Notes: No maintenance financial covenants

4.875% Senior Notes: No maintenance financial covenants

Debt Maturities by Year

( 1 ) U n d r a wn A B L r e v o l v e r b a l a n c e r e f l e c t s p r o f o r ma i mp a c t o f u s e o f p r o c e e d s o f $ 2 5 0 mi l l i o n s e n i o r s e c u r e d n o t e s o f f e r i n g c o mp l e t e d o n M a y 4 , 2 0 2 0 .

|15

COVID-19 RESPONSE – AUSTERITY MEASURES

EXTENSIVE COST ACTIONS IN PLACE EXPECTED TO DRIVE SAVINGS OF ~$15M OR MORE IN SECOND QUARTER VS. PRIOR YEAR BASE

Summary of Cost and Cash Actions Implemented

• Senior management and Board of Directors compensation reductions

• Furloughs and/or usage of accrued leave to reduce salary costs across all regions

• Delay in annual merit salary increases

• Temporary closure of certain manufacturing actions

• Hiring freeze

• Travel restrictions

• Elimination of discretionary spend

• Suspended all non-essential capital expenditures

• Opportunistic actions with supplier base for price reductions or payment terms

• Monitoring accounts receivable aging and credit limits

• Pursuing COVID-19 related government subsidies and tax deferrals

|16

ACTION PLANS IDENTIFIED TO MITIGATE COVID-19 RISKS

OUTLOOK

▪ Completed sensitivity analysis for multiple scenarios of demand impact from COVID-19

▪ Cost reduction and liquidity actions are in place; additional levers identified and can be

implemented depending on future conditions

▪ Near-term decremental margins benefit from cost reduction actions and improved pricing

▪ Expect that austerity measures will result in solid full year free cash flow performance under

various scenarios

▪ Near-term capital allocation plan focused on maximizing liquidity and minimizing risks

|

APPENDIX

|18

NON-GAAP RECONCILIATIONADJUSTED EBITDA (USD in millions)

(1) Impairment and restructuring charges consist of (i) impairment and restructuring charges that are included in our unaudited

consolidated statements of operations plus (ii) additional charges relating to inventory and/or manufacturing of our products that are

included in cost of sales in the accompanying unaudited consolidated statements of operations in the amount of $0.2 and $0.4 for the

three months ended March 28, 2020 and March 30, 2019, respectively.

(2) Other non-recurring items not core to ongoing business activity include: (i) in the three months ended March 28, 2020 (1) $11.7 in

legal costs and professional expenses relating primarily to litigation, (2) $3.1 in facility closure and consolidation costs related to our

facility footprint rationalization program, (3) $1.2 for one-time lease termination charges; (ii) in the three months ended March 30,

2019 (1) $4.8 in facility closure and consolidation costs related to our facility footprint rationalization program, (2) $2.9 in

acquisition and integration costs, (3) $1.6 in legal costs and professional expenses relating primarily to litigation.

Three Months Ended

March 28,

2020

March 30,

2019

Net income (loss) $ (0.2) $ 15.8

Income tax expense 1.2 10.3

Depreciation and amortization 33.5 30.9

Interest expense, net 16.6 17.7

Impairment and restructuring charges (1) 6.7 4.1

Loss (gain) on sale of property and equipment (2.1) 0.5

Share-based compensation expense 3.7 2.6

Non-cash foreign exchange transaction/translation (income)

loss (1.2) (3.7)

Other items (2) 16.3 10.4

Other non-cash items — 0.7

Adjusted EBITDA $ 74.5 $ 89.3

|19

NON-GAAP RECONCILIATIONADJUSTED NET INCOME AND FREE CASH FLOW (USD in millions)

(1) As a result of the 2019 revision, three months ended March 30, 2019 adjusted net income as presented herein was reduced by $0.9 million, and adjusted EPS was

reduced by $0.01.

Note: Except as otherwise noted, adjustments to net income and net income per share are tax-effected at an adjusted tax rate of 25.7% and 34.6%

for the three months ended March 28, 2020 and March 30, 2019, respectively. Excluding the impact of the GILTI provision, the first quarter

adjusted effective book tax rate would have been approximately 26% and 30% for the three months ended March 28, 2020 and March 30, 2019,

respectively.

(2) Dilutive shares for March 28, 2020 includes basic weighted average shares outstanding of 100,646,850 and the dilutive impact of restricted stock units,

performance share units, and options to purchase common stock of 979,341. Three Months Ended

March 28,

2020

March 30,

2019

Net cash provided by operating activities $ (76.5) $ (28.0)

Less capital expenditures 30.2 31.9

Free cash flow $ (106.7) $ (59.9)

Three Months Ended

(amounts in millions, except share and per share data)

March 28,

2020

March 30,

2019

Net income (loss) $ (0.2) $ 15.8

Legal costs and professional expenses 11.7 1.6

Non-cash foreign exchange transactions/translation (income) loss (1.2) (3.7)

Impairment and restructuring charges 6.7 4.1

Facility closure and consolidation charges 3.1 4.8

Acquisition and integration charges — 2.9

Adjusted tax impact (7.0) $ (3.3)

Adjusted net income (1) $ 13.1 $ 22.2

Diluted net income per share $ — 0.16

Legal and professional fees 0.12 0.02

Non-cash foreign exchange transactions/translation (income) loss (0.01) (0.04)

Impairment and restructuring charges 0.07 0.04

Facility closure and consolidation charges 0.02 0.04

Acquisition and integration charges — 0.03

Adjusted tax impact (0.07) $ (0.03)

Adjusted net income per share (1) $ 0.13 $ 0.22

Diluted shares used in adjusted EPS calculation represent the fully dilutive shares for

the three months ended March 28, 2020 and March 30, 2019, respectively.(2) 101,626,191 101,461,293